Ej. Kidd et al., CHARACTERIZATION OF THE NON-5-HT(3) HIGH-AFFINITY R-BINDING SITE FOR (R)-ZACOPRIDE IN BRAIN AND OTHER TISSUES, European journal of pharmacology. Molecular pharmacology section, 247(1), 1993, pp. 45-56
Previous studies showed that whereas the potent 5-HT3 receptor antagon
ist (S)-[H-3]zacopride only labels 5-HT3 receptor binding sites, the (
R)-enantiomer, (R)-[H-3]zacopride, labels these receptors and another
class of high-affinity binding sites, named the R sites, in membranes
from the rat cerebral cortex and NG 108-15 clonal cells (Kidd et al.,
Eur. J. Pharmacol. 211, 133, 1992). Further studies of R sites reveale
d that they existed not only in the cerebral cortex but also in variou
s other areas of the rat brain and spinal cord. In addition, R sites w
ere also found in post-mortem human brain tissues. Both in the rat and
in man, the regional distribution of central R sites was markedly dif
ferent from that of 5-HT3 receptors specifically labelled with (S)-[H-
3]zacopride. Under appropriate conditions for the specific labelling o
f R sites (with (R)-[H-3]zacopride in the presence of 1.0 muM ondanset
ron to saturate 5-HT3 receptor binding sites - and 0.1 mM mianserin fo
r the determination of non-specific binding), these R sites were also
found in rat peripheral tissues (intestine > spleen > kidney > testicl
es = liver > adrenals > lung > heart). At least in the kidney and the
liver, the pharmacological profile of R sites corresponded exactly to
that found in NG 108-15 cells. R sites were also detected in membranes
from C6 glioma cells and glial cells cultured from the whole cortex o
f new born rats. In contrast, no specific binding of (R)-[H-3]zacoprid
e to R sites could be found in membranes from N1E-115 neuroblastoma ce
lls. Conversely, 5-HT3 receptors could be labelled by (S)-[H-3]zacopri
de in the latter cells but not in C6 glioma and cultured glial cells.
As expected from their glial location, the density of R sites increase
d in the rat hippocampus lesioned with kainic or ibotenic acid to indu
ce local gliosis. In contrast, the density of hippocampal 5-HT3 recept
ors was unchanged in lesioned rats. Finally, the determination of the
apparent molecular size of R sites by radiation inactivation gave a va
lue (almost-equal-to 30 kDa) which was significantly lower than that o
f 5-HT3 receptor binding sites in the rat entorhinal cortex (40 kDa) a
nd NG 108-15 cells (57 kDa). All these data clearly showed that R site
s and 5-HT3 receptors are different molecular species. Whether R sites
mediate the 5-HT3 receptor-unrelated actions of (R)-zacopride deserve
s further investigations.